Winning in Biologicals Starts with Mastering the Fundamentals
Ask any coach what the key to winning is, and you’ll get a similar rallying cry: Execute the fundamentals. Sometimes in pursuit of something greater, like cutting-edge innovation, our mind gets pulled from the fundamentals, leading to failure and frustration.
We see this time and time again in the biologicals space: novelty in favor of consistency. It creates a false polarity in choice — we’ve become conditioned to believe it’s one or the other. There seem to be precious few companies with the ability to create both.
However, with biological products, including microbials, it’s key to nail the fundamentals: consistency of performance, clear returns on investment, and simplicity in use that adds value to existing tools and management practices.
The Key Fundamentals
As we in the ag industry consider strategic decisions about biologicals products on the farm and in the boardroom, we should look at key differentiators in the fundamentals.
- The foundational technology: Microbial collections built with purpose.
- How it works: Better understanding of the linkage between mode of action and performance.
- Ease of use: Options for application and formulations that work simply with existing products and systems.
- Proof points that matter: High-quality field data with relevant industry benchmarks that reflect performance in diverse conditions that enable product advancement and placement decisions.
- Consistency of performance: Consistency will create market confidence. Consistency is fundamental, and while that isn’t flashy, it is differentiating at this moment.
To deliver on the fundamentals in microbial products, we need to know what we are working with and embrace a biologicals playbook that is built on rigorous testing and analysis to understand how living things will have success in real-world agriculture. Akin to product development in the seed industry, to have consistent performance across growing conditions, you must understand how these products work, with what the microbes work best, and where performance falters. This leads to a deeper understanding of performance potential, factors for improving stability, and opportunities for performance enhancement.
These foundational principles should shape how startup/scale-up companies deploy capital.
Tips for Growth
To grow, companies should focus on assessing commercial viability through high-quality field trials with rigorous data quality for their partners. For example, a win should be defined by return on investment, not just positive yield advantage. Why? Because for farmers and channel partners, there is a cost to doing something different or adding a new product. Even if you remove all the friction in that change, farmers still need to have conviction that the benefit of the return will outweigh the cost of the change, and economic sustainability must always be top of mind, now more than ever.
Once the fundamentals are taken care of, companies must push for continuous improvement:
- Unlocking the potential of the microbiome.
- Better formulation and delivery technologies.
- Added functionality by tapping into the complex genomes of certain key microbes.
- Accelerating return on R&D investment by leveraging life-cycle management mindsets, by shortening the time to launch next-generation products, and by advancing highest potential products with increasing quality and quantity of performance data.
Ag innovators are being called to accelerate their advancements with foundational purpose and to improve delivery of product performance fundamentals to farmers.
It’s clear that the biologicals space is craving innovation. We see continued strategic activity like investments, partnerships, and joint development, all of which are signals from across the ag industry that there is a need for better products.
Our new discoveries should create a flywheel of growth: The better we get, the better we can get. Let this be our collective charge as an industry: to deliver on the fundamentals with each innovation and drive improvement at each step.
While this may sound simple, it certainly isn’t easy. Being uncompromising in consistency taxes people, systems, and the status quo, but it’s the only way we’ll reach excellence in new product innovation and create the kind of confidence it will take to drive market adoption.
Read more articles like this one in AgriBusiness Global’s 2026 Biologicals Deep Dive.